23.
Pacher P, Beckman JS, Liaudet L. “Nitric Oxide and Peroxynitrite in Health and Disease.”
Physiological
Reviews.
Vol.
87,
no.
1.
(January
2007):
315–424.
doi:
10.1152/physrev.00029.2006.
24.
Reczek CR, Chandel NS. “ROS-Dependent Signal Transduction.” Current Opinion in Cell
Biology. Vol. 33. (April 2015): 8–13. doi: 10.1016/j.ceb.2014.09.010.
25.
Fat ƒor Fuel. Dr. Joseph Mercola. Hay House. Carlsbad, California. 2017.
26.
Sohal RS, Weindruch R. “Oxidative Stress, Caloric Restriction, and Aging.” Science. Vol.
273, no. 5271. (July 5, 1996): 59–63. doi: 10.1126/science.273.5271.59.
27.
Salminena A, Kauppinenc A, Hiltunena M, Kaarnirantac K. “Krebs Cycle Intermediates
Regulate DNA and Histone Methylation: Epigenetic Impact on the Aging Process.” Ageing
Research Reviews. Vol. 16. (July 2014): 45–65. doi: 10.1016/j.arr.2014.05.004.
28.
Consales C, Merla C, Marino C, Benassi B. “Electromagnetic Fields, Oxidative Stress, and
Neurodegeneration.” International Journal oƒ Cell Biology. Vol. 2012. (2012): 683897. doi:
10.1155/2012/683897.
29.
Sawyer DT, Valentine J. “How Super Is Superoxide?” Accounts oƒ Chemical Research. Vol.
14, no. 12. (December 1, 1981): 393–400.
30.
Huie RE, Padmaja S. “The Reaction Rate of Nitric Oxide with Superoxide.” Free Radical
Research Communications. Vol. 18. (1993): 195–199.
31.
Yetik-Anacak G, Catravas JD. “Nitric Oxide and the Endothelium: History and Impact on
Cardiovascular Disease.” Vascular Pharmacology. Vol. 45, no. 5. (November 2006): 268–
276. doi: 10.1016/j.vph.2006.08.002.
32.
Griffith TM, Edwards DH, Davies RL, Harrison TJ, Evans KT. “EDRF Co-ordinates the
Behaviour of Vascular Resistance Vessels.” Nature. Vol. 329. (1987): 442–445.
33.
Hibbs JB Jr. “Synthesis of Nitric Oxide from L-arginine: A Recently Discovered Pathway
Induced by Cytokines with Antitumour and Antimicrobial Activities.” Research in
Immunology. Vol. 142, no. 7. (1991): 565–569. doi: 10.1016/0923-2494(91)90103-P.
34.
Förstermann U. “Nitric Oxide and Oxidative Stress in Vascular Disease.” Pƒlügers Archiv:
European Journal oƒ Physiology. Vol. 459, no. 6. (May 2010): 923-39. doi: 10.1007/s00424-
010-0808-2.
35.
Ziche M, Morbidelli L. “Nitric Oxide and Angiogenesis.” Journal oƒ Neuro-oncology. Vol.
50, no. 1-2. (October-November 2000):13-48. doi: 10.1023/a:1006431309841.
36.
Fode M, Jensen CFS, Østergren PB. “Sildenafil in Postprostatectomy Erectile Dysfunction
(Perspective).” International Journal oƒ Impotence Research. Vol. 31, no. 2. (March 2019): 61–
64. doi: 10.1038/s41443-018-0102-y.
37.
Pacher P, Szabo C. “Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in
Human Disease.” American Journal oƒ Pathology. Vol. 173, no. 1. (July 2008): 2–13. doi:
10.2353/ajpath.2008.080019.
38.
Radi R. “Peroxynitrite, a Stealthy Biological Oxidant.” Journal oƒ Biological Chemistry. Vol.
288, no. 37. (September 13, 2013): 26464–26472. doi: 10.1074 /jbc.R113.472936.
39.
Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. “Apparent Hydroxyl Radical
Production by Peroxynitrite: Implications for Endothelial Injury from Nitric Oxide and
